1. The Effect of a Standardized Ginger Extract on Chemotherapy-Induced Nausea-Related Quality of Life in Patients Undergoing Moderately or Highly Emetogenic Chemotherapy: A Double Blind, Randomized, Placebo Controlled Trial
- Author
-
Elisabeth Isenring, Anna Elizabeth Lohning, Karin Ried, Dan McKavanagh, Avni Sali, Luis Vitetta, Wolfgang Marx, and Alexandra L. McCarthy
- Subjects
Adult ,medicine.medical_specialty ,ginger ,nausea ,CINV ,dietary supplements ,cancer ,emesis ,Nausea ,Placebo-controlled study ,lcsh:TX341-641 ,Antineoplastic Agents ,Placebo ,Article ,03 medical and health sciences ,0302 clinical medicine ,Double-Blind Method ,Quality of life ,Internal medicine ,medicine ,Humans ,Retching ,030212 general & internal medicine ,Adverse effect ,Cancer-related fatigue ,Aged ,Uncategorized ,Nutrition and Dietetics ,Plant Extracts ,business.industry ,Middle Aged ,030220 oncology & carcinogenesis ,Anesthesia ,Quality of Life ,Vomiting ,medicine.symptom ,business ,lcsh:Nutrition. Foods and food supply ,Food Science - Abstract
Ginger supplementation could be an effective adjuvant treatment for chemotherapy-induced nausea (CIN). The aim of this clinical trial was to address significant methodological limitations in previous trials. Patients (N = 51) were randomly allocated to receive either 1.2 g of standardised ginger extract or placebo per day, in addition to standard anti-emetic therapy, during the first three cycles of chemotherapy. The primary outcome was CIN-related quality of life (QoL) measured with the Functional Living Index- Emesis (FLIE) questionnaire. Secondary outcomes included acute and delayed nausea, vomiting, and retching as well as cancer-related fatigue, nutritional status, and CIN and vomiting-specific prognostic factors. Over three consecutive chemotherapy cycles, nausea was more prevalent than vomiting (47% vs. 12%). In chemotherapy Cycle 1, intervention participants reported significantly better QoL related to CIN (p = 0.029), chemotherapy-induced nausea and vomiting (CINV)-related QoL (p = 0.043), global QoL (p = 0.015) and less fatigue (p = 0.006) than placebo participants. There were no significant results in Cycle 2. In Cycle 3, global QoL (p = 0.040) and fatigue (p = 0.013) were significantly better in the intervention group compared to placebo. This trial suggests adjuvant ginger supplementation is associated with better chemotherapy-induced nausea-related quality of life and less cancer-related fatigue, with no difference in adverse effects compared to placebo.
- Published
- 2023
- Full Text
- View/download PDF